Thursday, August 25, 2005

Canada Reinstates Deadly Attention Deficit Drug

Adderall XR, which was forced off the Canadian market last February, is being reinstated. The reversal of the Canadian regulator's decision came after a panel of experts reviewed the drug's safety data.

Health Canada pulled Adderall XR off the market on Feb. 9 after learning of 20 cases of sudden death and 12 of stroke in people using the drug. Fourteen of the sudden deaths and two of the strokes were in children. A number of the cases involved children with structural heart defects.

The drug was put back on the market because "there was not enough evidence of an increased harm from Adderall compared to other therapies available."

Health officials expect to have the product back on pharmacy shelves within the next two to three weeks.

1 comment:

Anonymous said...